Symic Bio grabs $11 mln

Emeryville, California-based Symic Bio, a biopharmaceutical company, has raised $11 million. Cell Innovation Partners led the round.

26 April 2019•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.